Joseph H. Wender, Director at ISIS PHARMACEUTICALS INC (ISIS), sold 7,000 shares at $65.97 ($462K) on 2015-03-02, disclosed to the SEC on 2015-03-04.
Open-market sale of $462k ISIS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2025-10-02 | $1.1M | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |